Nppa

Rediff.com » News » Nppa

News for Nppa

News
Business

Why Dolo, Saridon, Calpol Will Have QR Codes

IMAGE: Kindly note the image has been posted only for representational purposes. Photograph: Kind courtesy Castorly Stock/Pexels.com and Pixabay.com The top 300 pharmaceutical brands in the......

Trade margins capped at 70% for oximeters, BP meters, other medical devices

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products. IMAGE:......

3 lakh remdesivir to be produced daily in 15 days: Govt

The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.......

Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

Delhi HC sets aside government decision to cap condom prices

In a relief to pharma majors, the Delhi high court on Friday held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the luxury variety. A......

Govt to Monitor Non-Essential Drug Prices

The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs. Kindly note the image has been posted only for representational purposes.......

No need to relabel existing medicine stock: FinMin

Recalling or relabelling medicines already in the supply chain before September 22 will not be mandatory, the finance ministry said on Tuesday, issuing a fresh set of frequently asked questions......

NPPA heat on hospitals for failing to provide stent details

The regulator is now probing 24 hospitals, including Max Hospital in New Delhi and Lilavati in Mumbai, for allegedly overcharging patients for stents The National Pharmaceutical Pricing Authority......

NPPA pulls up cipla, Ranbaxy for overcharging

Leading pharmaceutical firms such as Cipla and Ranbaxy are among the firms pulled up by the drug price regulator National Pharmaceuticals Pricing Authority (NPPA) for overcharging. According to the......

NPPA slaps Rs 300-crore penalty on Novartis

Drug major Novartis has been slapped with a Rs 300-crore (Rs 3 billion) penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine. The Swiss......

Nppa

News for Nppa

Why Dolo, Saridon, Calpol Will Have QR Codes

Trade margins capped at 70% for oximeters, BP meters, other medical devices

3 lakh remdesivir to be produced daily in 15 days: Govt

Govt waives import duty on Remdesivir

Delhi HC sets aside government decision to cap condom prices

Govt to Monitor Non-Essential Drug Prices

No need to relabel existing medicine stock: FinMin

NPPA heat on hospitals for failing to provide stent details

NPPA pulls up cipla, Ranbaxy for overcharging

NPPA slaps Rs 300-crore penalty on Novartis

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS